Preliminary BCI 2017 Results and New Impact Analysis Published

Posted by:

In a world of global investment flows, securing a larger portion of the $150 billion invested per year by the research-based biopharmaceutical industry is anyone’s game. The 2017 results of the annual Biopharmaceutical Competitiveness & Investment (BCI) Survey, previewed at the International BIO Convention in San Diego in June, reveal that biopharmaceutical competitiveness turns on the policy conditions that countries decide to put in place.

 

A new blog post by Prof Meir Pugatch on PhRMA’s The Catalyst discusses these results and ...

Continue Reading →
0

BIO 2017

Posted by:

Professor Meir Pugatch and Dr. David Torstensson are speaking today at the BIO international convention held in San Diego, CA. Sponsored by the Biotechnology Innovation Organization, the annual convention hosts more than 16,000 attendees from over 70 countries.

 

Yesterday Professor Pugatch participated in a high level discussion within the What in the World Matters? The Challenge of Spurring Innovation in Global Markets panel, which focused on the relatively slow uptake of biotech innovation in economies outside the US, and ...

Continue Reading →
0

Building a Bioeconomy: A how-to guide

Posted by:

New study shows how countries can succeed in developing and building their biotech capabilities

A new study by international research consultancy Pugatch Consilium (commissioned by the Biotechnology Industry Organization) examines those national innovation strategies, policies and best practices that have been successful in creating an environment in which biotechnologies and biotechnological innovation can flourish.

2017 marks the fourth edition of the Building the Bioeconomy series of papers examining national biotechnology industrial policies. This year’s edition includes 26 countries from all major regions ...

Continue Reading →
0

III Semana de Innovación en Salud (Week of Innovation in Health) Event

Posted by:

Ma’ayan Laufer, a Senior Consultant at Pugatch Consilium, spoke last week at the III Semana de Innovación en Salud (Week of Innovation in Health) event, held at Mexico City. Ma’ayan’s presentation focused on Mexico’s performance vis-à-vis global leaders in biomedical innovation as reflected in Pugatch Consilium’s international indices – including the Building the Bioeconomy series, the International IP Index and the Biopharmaceutical Competitiveness and Investment (BCI) Index.

Continue Reading →

0

Professor Meir Pugatch and U.S. Chamber of Commerce President Tom Donohue launch new fifth edition of the U.S. Chamber of Commerce’s International IP Index

Posted by:

Professor Meir Pugatch spoke together with Tom Donohue (President and CEO of the U.S. Chamber of Commerce), David Hirschmann (President and CEO of the U.S. Chamber of Commerce Global Intellectual Property Center) and former Director of the United States Patent and Trademark Office, David Kappos, at the launch of the fifth edition of the U.S. Chamber’s International IP Index in Washington D.C earlier this week.

Continue Reading →

0

Pugatch Consilium Releases New Study on Regulatory Standards for Approval of Generic Medicines

Posted by:

Today Pugatch Consilium releases Generic drugs appraisal and approval: departing from the ‘one-size-fits-all’ approach.

Generic medicines – follow-on versions of off-patent innovative medicines – are designed to be interchangeable to the innovative reference product. As more sophisticated and complex medicines are developed, securing the safe and effective use of their follow-on products becomes increasingly challenging.

This report zeroes in on the existing gaps and challenges within the ‘one-size-fits-all’ model of generic drugs approval vis-à-vis two particularly complex drugs: Narrow Therapeutic Index (NTI ...

Continue Reading →
0

¿Cómo ser más competitivo? How to increase competitiveness – a Semana Magazine interview with Ma’ayan Laufer, Senior Consultant at Pugatch Consilium

Posted by:

Today Semana Magazine, Colombia’s leading and international prize-winning magazine, published the article: ¿Cómo ser más competitivo? (How to increase competitiveness?) following an exclusive interview with Ma’ayan Laufer, a senior consultant at Pugatch Consilium. The interview took place last week, right after the launch of Pugatch Consilium’s recent report: “Challenges and Opportunities – Developing the Biotechnology Sector in Colombia” at the Bionovo conference in Bogotá, Colombia [BioNovo]

The key findings of the report, that Colombia could see over 100 new clinical ...

Continue Reading →
0

New Pugatch Consilium report finds Colombia could see over 100 new clinical trials and up over $450 million in economic gains per year with policy reform

Posted by:

Today Pugatch Consilium releases Challenges and Opportunities – Developing the Biotechnology Sector in Colombia.

The purpose of this report is to, firstly, give a comparative overview of the biotechnology sector in Colombia and, secondly, provide an estimate of how an improvement to Colombia’s policy environment can result in higher biotechnology outputs including rates of biomedical FDI and clinical trials.

The report maps the current policy environment as it relates to biotechnology in Colombia and gives a detailed comparison on key major biotechnology ...

Continue Reading →
0

Pugatch Consilium launches 2016 BCI Survey

Posted by:

Pugatch Consilium has launched the third edition of the Biopharmaceutical Competitiveness & Investment (BCI) Survey: The Race for Biopharmaceutical Innovation.

A global executive opinion survey and index of economies’ attractiveness for biomedical investment, in 2016 the BCI covers 28 strategic markets and gauges individual markets in relation to others with similar levels of development. The study was released in Washington DC and Ottawa, Canada, with other local and regional launches to take place throughout the remainder of the year.

Key findings of the ...

Continue Reading →
0

Pugatch Consilium’s BCI Survey used at the BioBusiness Asia Conference

Posted by:

Pugatch Consilium’s Biopharmaceutical Competitiveness & Investment Survey – known as the BCI – gained much attention when presented by Taiwan’s Vice-President, Chien-Jen Chen in his opening remarks at the BioBusiness Asia Conference which took place last week in Taipei.

VP Chen discussed the growth and development of Taiwan’s biotech industry, the challenges that still remain, and the new governmental policies in six areas of priorities in the biomedical industry, including increased efforts to harmonize the IP and legislative environments with international ...

Continue Reading →
0
Page 1 of 13 12345...»